Fresenius Kabi sells German oncology compounding business

BERLIN (Reuters) - Fresenius Kabi has sold its German oncology business CFL GmbH to fellow compounding compay NewCo Pharma GmbH for an undisclosed amount, the company said on Monday. Fresenius Kabi AG is a wholly owned subsidiary of German healthcare group Fresenius SE & Co. KGaA . Fresenius Kabi will remain active in compounding, it said. (Reporting by Andreas Cremer; Editing by Greg Mahlich)